Yali Zhang

Yali Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Open Medicine
Verified
Journal Article
Open access
PDF file
NMNa Mi
Na Mi
LMLili Ma
Lili Ma
XLXueying Li
Xueying Li
JFJia Fu
Jia Fu
XBXinxin Bu
Xinxin Bu
LYLifen Yao
Lifen Yao
The gut microbiota and microbial metabolites influence the enteric nervous system and the central nervous system via the microbial–gut–brain axis. Increasing body of evidence suggests that disturbances in the metabolism of peripheral branched-chain amino acids (BCAAs) can contribute to the development of neurodegenerative diseases through neuroinflammatory signaling. Preliminary research has shown that longitudinal changes in serum amino acid levels in mouse models of Parkinson’s disease (PD) are negatively correlated with disease progression. Therefore, the aim of the present study was to determine the changes in serum levels of short-chain fatty acids (SCFAs) in a mouse model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD after dietary BCAA supplementation. In our research, gas chromatography–mass spectrometry was used to detect serum SCFA concentrations. The data were then analyzed with principal component analysis and orthogonal partial least squares discriminant analysis. Finally, the correlations of serum SCFA levels with gut and motor function in MPTP-induced PD mice were explored. Propionic acid, acetic acid, butyric acid, and isobutyric acid concentrations were elevated in MPTP + H-BCAA mice compared with MPTP mice. Propionic acid concentration was increased the most, while the isovaleric acid concentration was decreased. Propionic acid concentration was positively correlated with fecal weight and water content and negatively correlated with the pole-climbing duration. In conclusion, these results not only suggest that propionic acid may be a potential biomarker for PD, but also indicate the possibility that PD may be treated by altering circulating levels of SCFA.

1 December 2024 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
MSManqiqige Su
Manqiqige Su
XLXiaoqing Liu
Xiaoqing Liu
ZWZongtai Wu
Zongtai Wu
JSJie Song
Jie Song
XHXiao Huan
Xiao Huan
SLSushan Luo
Sushan Luo
Background: Myasthenia gravis (MG) is an autoimmune disease mediated by autoantibodies primarily affecting the neuromuscular junction. This study aims to identify risk factors for pregnancy-related MG relapse and develop a predictive model to improve clinical outcomes. Methods: We enrolled 113 MG female patients with a pregnancy history during follow-up at Huashan Hospital affiliated with Fudan University, between January 2015 and October 2021. The study analyzed relapse rates and risk factors during pregnancy and postpartum using multivariate logistic regression. A nomogram was constructed to predict relapse probability, with model performance evaluated by discrimination and calibration metrics. Results: Of the 113 patients, 52 (46.02%) experienced 115 relapses, including 52 (45.22%) occurring during the first trimester of pregnancy, 11 (9.56%) during the second trimester of pregnancy, and 52 relapses (45.22%) during the three months after delivery/abortion. Significant factors associated with pregnancy-relate relapse, included age at delivery/abortion (OR 0.21, 95% CI 0.06–0.65), MG stable duration (OR 0.24, 95% CI 0.09–0.63), thymic hyperplasia (OR 3.45, 95% CI 1.35–9.3), pre-pregnancy thymectomy (OR 0.08, 95% CI 0.01–0.36), and inadequate treatment during pregnancy (OR 4.44, 95% CI 1.35–17.76). The Nomogram model demonstrated robust predictive performance. Conclusion: The first trimester of pregnancy and three months following delivery or abortion are high-risk periods for MG relapse. Younger ages, shorter MG stable duration before pregnancy, thymic hyperplasia, and inadequate treatments during pregnancy increase relapse risk.

15 July 2025 in Scientific Reports
Verified
Journal Article
Open access
JFJia Fu
Jia Fu
JZJing Zhao
Jing Zhao
XZXue Zhao
Xue Zhao
NMNa Mi
Na Mi
CZChao Zhang
Chao Zhang
LYLifen Yao
Lifen Yao
There is a strong relationship between metabolic cell death (MCD) and neurodegenerative diseases. However, the involvement of metabolic cell death (MCD)-related genes (MCDRGs) in Parkinson's disease (PD) pathogenesis remains poorly analyzed. Integrating PD-associated differentially expressed genes (DEGs) from GSE7621 with MCDRGs, we identified key biomarkers through protein-protein interaction networks and machine learning. Diagnostic performance was validated through nomogram analysis. Subsequent analyses included functional enrichment, immune profiling, drug prediction, and single-cell RNA sequencing. AKR1C2 and MAP1LC3A were identified as potential biomarkers. A nomogram with superior diagnostic performance was constructed. Gene set enrichment analysis indicated that both biomarkers were linked to the "Parkinson's disease". Further, immune infiltration revealed that AKR1C2 had the remarkably strongest positive correlation with M2 macrophages. Moreover, benzo[a]pyrene-1,6-dione, mestranol, and paraoxon-methyl might be potential therapeutic agents for PD. Single-cell RNA-seq analysis demonstrated endothelial-specific expression, with MAP1LC3A and AKR1C2 exhibiting distinct temporal regulation during differentiation. AKR1C2 and MAP1LC3A were identified as potential biomarkers associated with MCD in PD. These results offer fresh concepts for PD prevention and diagnosis.

29 November 2025 in Brain and Behavior
Verified
Journal Article
Open access
JFJia Fu
Jia Fu
JZJing Zhao
Jing Zhao
NMNa Mi
Na Mi
CZChao Zhang
Chao Zhang
YZYali Zhang
Yali Zhang
LYLifen Yao
Lifen Yao
Background: The pathogenesis of Parkinson's disease (PD) is closely linked to ferroptosis, yet the mechanism by which ferroptosis‐related proteins modulate PD risk through genetic variations remains unclear. Methods: We performed two‐sample Mendelian randomization (MR) analyses using protein quantitative trait loci (pQTLs) from the UKB‐PPP and deCODE studies as instrumental variables, combined with PD genome‐wide association study (GWAS) data. The inverse variance weighting (IVW) method served as the primary analytical approach to identify PD‐associated proteins. To assess the role of ferroptosis‐related proteins in PD, a two‐step MR mediation analysis was conducted, followed by multiple sensitivity analyses. Transcriptomic datasets were analyzed to confirm the differential expression of genes encoding prioritized proteins. Publicly available single‐cell RNA sequencing data were utilized to investigate cell‐type‐specific expression patterns and functional pathways of key proteins. Results: A total of 210 proteins significantly associated with PD were identified ( p <0.05). Mediation analysis demonstrated that CCNE1 mediated 44.17% of the neuroprotective effect ( β = −0.503, p = 5.8 × 10 −4 ) through upregulating PARP16 expression ( β = 0.318, p = 2.36 × 10 −18 ), with CCNE1's differential expression further validated in transcriptomic datasets. Single‐cell analysis demonstrated that CCNE1 and PARP16 are specifically highly expressed in neurons ( p < 0.05), with neurons being significantly enriched in neural survival and synaptic plasticity pathways. The cell interaction network revealed that neurons specifically communicate with astrocytes via the NRG3‐ERBB4 pathway. Conclusion: This study provides the first molecular insight into how CCNE1 exerts neuroprotective effects through the regulation of the ferroptosis key protein PARP16, offering a novel perspective for PD mechanism research.

20 May 2026 in Molecular Immunology
Verified
Journal Article
Closed access
NMNa Mi
Na Mi
LMLili Ma
Lili Ma
JZJing Zhao
Jing Zhao
XBXinxin Bu
Xinxin Bu
JXJing Xu
Jing Xu
LYLifen Yao
Lifen Yao

10 July 2025 in Mammalian Genome
Verified
Journal Article
Closed access
PDF file
JFJia Fu
Jia Fu
JZJing Zhao
Jing Zhao
NMNa Mi
Na Mi
CZChao Zhang
Chao Zhang
YZYali Zhang
Yali Zhang
LYLifen Yao
Lifen Yao